Added successfully to RFQ list

Added successfully to compare list

Prof-Kirill-Alexandrov_1 2

Prof Kirill Alexandrov

CSIRO-QUT Synthetic Biology Alliance

We have worked with o2h team on a range of synthetic projects and had consistently positive experience. The combination of competence, effective project management...Read more

company-logo
Prof-Kirill-Alexandrov_1 2

Prof Kirill Alexandrov

CSIRO-QUT Synthetic Biology Alliance

We have worked with o2h team on a range of synthetic projects and had consistently positive experience. The combination of competence, effective project management and detailed documentation made us go back again and again. The company offers excellent value for money and makes a significant effort to work within the given funding envelope.

Image 2 (2)

Sharon Shacham

Co-Founder & MD, E44 Ventures

My relationship with o2h Discovery is now more than a decade. I have had many opportunities to collaborate with the o2h team for my drug discovery...Read more

company-logo
Image 2 (2)

Sharon Shacham

Co-Founder & MD, E44 Ventures

My relationship with o2h Discovery is now more than a decade. I have had many opportunities to collaborate with the o2h team for my drug discovery efforts at Karyopharm, Protai and Sporos Bioventures. I have always been impressed by their efficiency to deliver novel chemical compounds that helps to achieve targeted project milestones. Real time and insightful communication is also their key differentiator. I think the o2h kickstarter competition is a great initiative that can help the early-stage companies to get expert chemistry services for generating valuable chemical matter for their drug discovery programs. It should definitely provide a boost to their initial research efforts. I wish o2h Discovery and their kickstarter partners all the very best.

Brian-Dymock_1 1

Brian Dymock

Head of QEDDI

Our relationship with o2h over many years supporting our medicinal chemistry projects in QEDDI has been highly productive...Read more

company-logo
Brian-Dymock_1 1

Brian Dymock

Head of QEDDI

Our relationship with o2h over many years supporting our medicinal chemistry projects in QEDDI has been highly productive. With o2h’s help we have progressed our portfolio to an advanced stage ready for partnering. We are very pleased with the efficiency, productivity and communication with o2h chemists and look forward to further positive outcomes.

Image 1

Beth J Hoffman

CEO, Origami Therapeutics

We’re thrilled to have been selected for the o2h Kickstarter program and to have the opportunity to work with the skilled chemists at o2h...Read more

company-logo
Image 1

Beth J Hoffman

CEO, Origami Therapeutics

We’re thrilled to have been selected for the o2h Kickstarter program and to have the opportunity to work with the skilled chemists at o2h. The Kickstarter will enable us to thoroughly explore our nascent SAR and advance our lead program more rapidly.

Julian Blagg

Julian Blagg

Executive Vice President, Drug Discovery

NeoPhore has worked closely with o2h for over 4 years, consistently supporting NeoPhore with small and medium scale synthesis...Read more

company-logo
Julian Blagg

Julian Blagg

Executive Vice President, Drug Discovery

NeoPhore has worked closely with o2h for over 4 years, consistently supporting NeoPhore with small and medium scale synthesis and characterisation of novel small molecule therapeutics; work that has enabled significant Series A and Series B investment. NeoPhore highly values the synthetic expertise, efficiency, project management and clear communication at o2h. Importantly, o2h benefits from highly integrated analytical and compound purification groups to enable consistent and smooth delivery of high quality target compounds to tight deadlines. Furthermore, flexibility of resourcing at o2h is ideally suited to support an evolving small biotech company like NeoPhore.

Bharat Majeti

Bharat Majeti

Head of LNP Technology, RVAC Medicines

We understand that lipid chemistry is complex and requires significant expertise in synthesis, purification, and analysis...Read more

company-logo
Bharat Majeti

Bharat Majeti

Head of LNP Technology, RVAC Medicines

We understand that lipid chemistry is complex and requires significant expertise in synthesis, purification, and analysis. Therefore, we looked for a competent and reliable CRO partner to support our requirements and found o2h Discovery. We have done several projects with o2h.